These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20022432)

  • 1. Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease.
    Goldberg JS
    Med Hypotheses; 2010 Apr; 74(4):629-30. PubMed ID: 20022432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues in blood transfusion for sickle cell disease.
    Wahl S; Quirolo KC
    Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated red cell exchange procedures in patients with sickle cell disease.
    Kozanoglu I; Boga C; Ozdogu H; Sezgin N; Kizilkilic E; Kural M
    Transfus Apher Sci; 2007 Jun; 36(3):305-12. PubMed ID: 17584530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion in sickle cell disease.
    Marouf R
    Hemoglobin; 2011; 35(5-6):495-502. PubMed ID: 21981466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
    Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transfusion therapy in the treatment of sickle cell disease.
    Miller C
    J Intraven Nurs; 1994; 17(2):70-3. PubMed ID: 8064491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A palliative care approach in treating patients with sickle cell disease using exchange transfusion.
    Navaid M; Melvin T
    Am J Hosp Palliat Care; 2010 May; 27(3):215-8. PubMed ID: 20167836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion management in sickle cell disease.
    Wanko SO; Telen MJ
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(2):83-97. PubMed ID: 15004333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
    Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
    Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report.
    Tiftik N; Altintaş E; Kiykim A; Uçbilek E; Sezgin O
    J Clin Apher; 2004; 19(1):17-9. PubMed ID: 15095397
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD; Williams ME
    Ann Clin Lab Sci; 1986; 16(3):214-8. PubMed ID: 3717883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.
    Cabibbo S; Fidone C; Garozzo G; Antolino A; Manenti GO; Bennardello F; Licitra V; Calabrese S; Costantino F; Travali S; Distefano R; Bonomo P
    Transfus Apher Sci; 2005 Jun; 32(3):315-21. PubMed ID: 15908276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.